JIJITANG2014-11-24 2:58 PM


Researchers are testing a protein therapy that stops breast and ovarian cancer from metastasizing in mice .

“ The majority of patients who succumb to cancer fall prey to metastatic forms of the disease , ” says Jennifer Cochran, an associate professor of bioengineering at Stanford University .

Today doctors try to use chemotherapy to slow or stop cancer from spreading from the original tumor site to other parts of the body , but these treatments are unfortunately not very effective and have severe side effects .

The new therapy doesn’t have side effects. It works by preventing two proteins–Axl and Gas6–from interacting to initiate the spread of cancer .

Axl proteins stand like bristles on the surface of cancer cells , poised to receive biochemical signals from Gas6 proteins .

When two Gas6 proteins link with two Axls, the signals that are generated enable cancer cells to leave the original tumor site , migrate to other parts of the body , and form new cancer nodules .

To stop this process Cochran used protein engineering to create a harmless version of Axl that acts like a decoy . This decoy Axl latches on to Gas6 proteins in the bloodstream and prevents them from linking with and activating the Axls present on cancer cells .


In collaboration with Amato Giaccia , professor of radiation oncology , the researchers gave intravenous treatments of this bioengineered decoy protein to mice with aggressive breast and ovarian cancers .

Mice in the breast cancer treatment group had 78 percent fewer metastatic nodules than untreated mice . Mice with ovarian cancer had a 90 percent reduction in metastatic nodules when treated with the engineered decoy protein .

A paper published in the journal Nature Chemical Biology details the results .

“This is a very promising therapy that appears to be effective and nontoxic in preclinical experiments ,” Giaccia says .“ It could open up a new approach to cancer treatment .”

Giaccia and Cochran are scientific advisors to Ruga Corp. , a biotech startup in Palo Alto that has licensed this technology from Stanford . Further preclinical and animal tests must be done before determining whether this therapy is safe and effective in humans .

Original Article:

《An engineered ​Axl 'decoy receptor' effectively silences the ​Gas6-​Axl signaling axis》,Published on Journal《Nature chemical biology》21 September ,  2014 .







0 Following 3 Fans 0 Projects 310 Articles


Changes to the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) have resulted in families eating more fruits and vegetable

Read More

In contests drawn from game theory, chimpanzee pairs consistently outperform humans in games that test memory and strategic thinking.A new study, condu

Read More

Publishing is one of the most ballyhooed metrics of scientific careers, and every researcher hates to have a gap in that part of his or her CV. Here’s

Read More

Pornography triggers brain activity in people with compulsive sexual behaviour -- known commonly as sex addiction -- similar to that triggered by drugs

Read More

In a recent survey, academic staff at the University identified the interrelated skills of writing and reasoning as the two most important skills for s

Read More

In a recent survey, academic staff at the University identified the interrelated skills of writing and reasoning as the two most important skills for s

Read More

Reading cautionary tales like The Boy Who Cried Wolf and Pinocchio to little kids might not be the best way to teach them to tell the truth.New researc

Read More

Those flat, glassy solar panels on your neighbor’s roof may be getting a more efficient makeover, thanks to a new class of solar-sensitive nanoparticle

Read More

Physicists have overcome a major challenge in the science of measurement using quantum mechanics. They’ve used multiple detectors to measure photons in

Read More

If you want to slow down long enough to smell the proverbial roses, you might want to move to a neighborhood with fewer drive-thru restaurants, researc

Read More